Skip to content
Screener

Savara SVRA Other Income (Expense)

Other Income (Expense) at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
-$15K+98.1%
XER
Xeris Biopharma Holdings, Inc.XERS
-$36.27M-466%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$3.98M-103%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$2.67M-39.1%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$468K-127%
PVL
Palvella TherapeuticsPVLA
-$32K-114%

Other financials

Income statement

See full
Revenue-
Operating income-$41.0M-30.3%
Net income-$40.2M-32.3%
EPS (diluted)-$0.16-14.3%

Balance sheet

See full
Cash & equivalents$41.8M+140%
Total debt$31.2M+5.2%
Total equity$143.7M+19.2%
Total assets$192.1M+17.3%

Cash flow

See full
Operating cash flow-$29.7M-13.3%
CapEx$222.0K+1,380%
Free cash flow-$30.0M-14.1%

Valuation

See full
Market cap$1.19B+152%
Enterprise value$1.18B+143%

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-105.5%+7.0pp
Debt / equity0.2×0.0×
Current ratio10.1×-0.9×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Savara’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344585
Line itemFor the three months ended June 30, 2026For the three months ended June 30, 2025For the six months ended June 30, 2026For the six months ended June 30, 2025
Tax credit income853784
Change in fair value of royalty agreement derivative liability(11)(23)
Loss on extinguishment of debt(546)
Total other income, net7371,0392,4432,834
Net loss$(40,228)$(30,401)$(77,512)$(57,040)
Net loss per share:
Basic and diluted$(0.16)$(0.14)$(0.31)$(0.26)
Weighted-average common shares outstanding:

Cover / Front Matter

FAQ

What is Savara's other income (expense)?
Savara (SVRA) reported other income (expense) of $737K in Q2 2026.
How has Savara's other income (expense) changed year-over-year?
Savara's other income (expense) decreased by 29.1% year-over-year, from $1.04M to $737K.
What is the long-term trend for Savara's other income (expense)?
Over 4 years (2021 to 2025), Savara's other income (expense) has grown at a 32.3% compound annual growth rate (CAGR), from -$1.54M to $4.71M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Savara's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude